ghk-cu upregulates col3a1 Copper Peptide Regeneration Review (2018) — Research Summary GHK-Cu Topical Serum: Benefits, Mechanism

A small, 7-day clinical trial, published in 2002 offered very little information other than the reporting of no significant adverse effects. Results from a clinical safety and pharmacokinetics study on BPC-157 registered with clinicaltrials.gov in 2015 have not yet been released (study status reported as unknown)

Cardiovascular Disease and Stroke Risk Despite the reduction in homocysteine levels, the combined supplementation of Vitamin B6 and B12 does not significantly impact the incidence of cardiovascular disease events or myocardial infarction

Chronic tinnitus resulting from cerumen removal procedures

The compound remains detectable in urine for up to 4 days by mass spectrometry methods, despite its short plasma half-life, suggesting tissue distribution and binding may extend its biological effects beyond plasma clearance times

How do I get started